|
|
||||||||
The Annals of Thoracic Surgery, Vol 56, 74-78, Copyright © 1993 by The Society of Thoracic Surgeons
RW Sawyer, WG Hammond, RL Teplitz and JR Benfield
For bronchogenic carcinoma, if and when the sequential process of
carcinogenesis is reversible is fundamental to chemoprevention research. In
our hamster model, focally originating non-small cell lung carcinoma
(NSCLC) develops via a reproducible sequential process of carcinogenesis by
180 days after endobronchial sustained-release implants (SRIs) of 10%
benzo(a)pyrene. In this study, 114 hamsters received removable 10%
benzo(a)pyrene SRIs. Short-term controls were sacrificed in 3 groups at 50,
65, and 80 days after SRI placement. Three experimental groups had SRIs
removed at 50, 65, and 80 days after placement, and sacrifice was delayed
until 100 to 180 days later. Long- term controls retained SRIs until
sacrifice at 180 or 240 days after SRI placement. All long-term controls
had NSCLC. Preneoplastic change was more common in 50- and 65-day controls,
as compared with hamsters with equal duration of SRI exposure whose
sacrifice was delayed until 100 to 180 days after SRI removal (p <
0.05). The 56% incidence of early NSCLC in hamsters sacrificed after 80
days of SRI exposure decreased to 5% in hamsters that had delayed sacrifice
after SRI removal after 80 days of exposure. At the 10% benzo(a)pyrene dose
used, hamster bronchial epithelium requires more than 80 days of continuous
exposure to become irreversibly committed to NSCLC uniformly. Microinvasive
NSCLC in hamsters often regresses, and it is not necessarily a precursor of
overt invasive cancer. The removable SRI model provides new opportunities
to evaluate chemoprevention of NSCLC and the related molecular-genetic
control mechanisms.
ARTICLES
Regression of bronchial epithelial cancer in hamsters
Department of Surgery, University of California Davis School of Medicine, Sacramento.
This article has been cited by other articles:
![]() |
B. D. Vincent, M. Fraig, and G. A. Silvestri A Pilot Study of Narrow-Band Imaging Compared to White Light Bronchoscopy for Evaluation of Normal Airways and Premalignant and Malignant Airways Disease Chest, June 1, 2007; 131(6): 1794 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Moro-Sibilot, F. Fievet, M. Jeanmart, S. Lantuejoul, F. Arbib, M.H. Laverriere, E. Brambilla, and C. Brambilla Clinical prognostic indicators of high-grade pre-invasive bronchial lesions Eur. Respir. J., July 1, 2004; 24(1): 24 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Moro-Sibilot, M. Jeanmart, S. Lantuejoul, F. Arbib, M. H. Laverriere, E. Brambilla, and C. Brambilla Cigarette Smoking, Preinvasive Bronchial Lesions, and Autofluorescence Bronchoscopy Chest, December 1, 2002; 122(6): 1902 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brambilla, S. Gazzeri, D. Moro, S. Lantuejoul, S. Veyrenc, and C. Brambilla Alterations of Rb Pathway (Rb-p16INK4-Cyclin D1) in Preinvasive Bronchial Lesions Clin. Cancer Res., February 1, 1999; 5(2): 243 - 250. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |